Contents include: 'Cytogenetic Abnormalities in Primary and Secondary MDS', 'Genomic Instability Syndromes and Myelodysplasia', 'FAB, WHO, IWG and Beyond', 'Supportive Treatment in Low and High Risk MDS', 'MPD/MDS Overlap Syndromes' and 'Emerging Therapies Including Lenolidamide'.